Found 668 matching trials
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
PHASE1Considerable progress in the treatment of metastatic melanoma has been made...
Location
Beijing Cancer Hospital
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
PHASE1The purpose of this study is to find the number of natural killer (NK) cell...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients
N/AThe purpose of this study is to collect data from patients by social media ...
Location
Lymphoma House086
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
Institute of Hematology & Blood Diseases Hospital
Immunologic Markers for the Differential Diagnosis Between Uveitis-TBC and Uveitis-SARC (TBC-SARC)
N/AToday there are no tests that allow to make a precise differential diagnosi...
Location
IRCCS/AUSL Reggio Emilia Hospital
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers
PHASE1This is an open-label, multi-center study to evaluate the safety, tolerabil...
Location
USC/Norris Comprehensive Cancer Center
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation
PHASE1The investigators propose a nonrandomized, Phase I study to assess the safe...
Location
Hammersmith Hospital
Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
PHASE1The aim of this study is the safety and efficacy of cryosurgery plus NK imm...
Location
Cancer Institute in Fuda cancer hospital
GKL-006Allo Injection in Patients With Advanced Solid Tumors
PHASE1This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Location
Cancer Hospital Chinese Academy of Medical Sciences
CIML NK Cell in Head & Neck Cancer
PHASE1This research study is evaluating the safety and efficacy of a combination ...
Location
Dana Farber Cancer Institute